Review



il 8 d8000c levels  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    R&D Systems il 8 d8000c levels
    Il 8 D8000c Levels, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 742 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il 8 d8000c levels/product/R&D Systems
    Average 97 stars, based on 742 article reviews
    il 8 d8000c levels - by Bioz Stars, 2026-05
    97/100 stars

    Images



    Similar Products

    97
    R&D Systems il 8 d8000c levels
    Il 8 D8000c Levels, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il 8 d8000c levels/product/R&D Systems
    Average 97 stars, based on 1 article reviews
    il 8 d8000c levels - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    97
    R&D Systems cxcl8 levels human il 8
    Cxcl8 Levels Human Il 8, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cxcl8 levels human il 8/product/R&D Systems
    Average 97 stars, based on 1 article reviews
    cxcl8 levels human il 8 - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    96
    R&D Systems c x c motif chemokine ligand 8 cxcl8 secretion levels
    IRE1α overexpression augments cytokine expression and increases glutamate clearance in human astrocytes. Backbone and IRE1α transfected astrocytes were treated with IL-1β for 24 h. (A–D) Cells were immunolabeled with antibodies specific for IRE1α (red) and the astrocyte marker glial fibrillary acidic protein (GFAP, green). Nuclear DNA was labeled with DAPI (blue). (E–G) Experiments in four separate biological donors were analyzed to quantify morphological activation. Individual dots on graphs represent compiled fold-changes calculated from duplicate wells and/or triplicate images per condition for each biological astrocyte donor. (E) GFAP intensity was measured across full-well scans using SoftMax Pro and normalized to DAPI. (F) Process length of individual astrocytes was manually traced and measured using ImageJ Software. (G) Percent morphological activation was calculated based on the number of astrocytes presenting with ‘reactive’ morphology divided by the total number of astrocytes imaged. (H) CCL2 and (I) <t>CXCL8</t> levels were assessed by an ELISA, and expression was normalized to metabolic activity prior to calculating fold changes to backbone. (J) Astrocytes were treated with 400 nM glutamate for 24 h. Remaining glutamate levels were quantified by fluorescent assay to calculate% glutamate clearance followed by fold change for each individual donor. Individual dots on graphs represent compiled data from triplicate experiments per biological astrocyte donor. Significance was determined by one-way ANOVA and Tukey’s post hoc for multiple comparisons.
    C X C Motif Chemokine Ligand 8 Cxcl8 Secretion Levels, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c x c motif chemokine ligand 8 cxcl8 secretion levels/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    c x c motif chemokine ligand 8 cxcl8 secretion levels - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    R&D Systems cytokine levels
    IRE1α overexpression augments cytokine expression and increases glutamate clearance in human astrocytes. Backbone and IRE1α transfected astrocytes were treated with IL-1β for 24 h. (A–D) Cells were immunolabeled with antibodies specific for IRE1α (red) and the astrocyte marker glial fibrillary acidic protein (GFAP, green). Nuclear DNA was labeled with DAPI (blue). (E–G) Experiments in four separate biological donors were analyzed to quantify morphological activation. Individual dots on graphs represent compiled fold-changes calculated from duplicate wells and/or triplicate images per condition for each biological astrocyte donor. (E) GFAP intensity was measured across full-well scans using SoftMax Pro and normalized to DAPI. (F) Process length of individual astrocytes was manually traced and measured using ImageJ Software. (G) Percent morphological activation was calculated based on the number of astrocytes presenting with ‘reactive’ morphology divided by the total number of astrocytes imaged. (H) CCL2 and (I) <t>CXCL8</t> levels were assessed by an ELISA, and expression was normalized to metabolic activity prior to calculating fold changes to backbone. (J) Astrocytes were treated with 400 nM glutamate for 24 h. Remaining glutamate levels were quantified by fluorescent assay to calculate% glutamate clearance followed by fold change for each individual donor. Individual dots on graphs represent compiled data from triplicate experiments per biological astrocyte donor. Significance was determined by one-way ANOVA and Tukey’s post hoc for multiple comparisons.
    Cytokine Levels, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cytokine levels/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    cytokine levels - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    R&D Systems il 8 levels
    IRE1α overexpression augments cytokine expression and increases glutamate clearance in human astrocytes. Backbone and IRE1α transfected astrocytes were treated with IL-1β for 24 h. (A–D) Cells were immunolabeled with antibodies specific for IRE1α (red) and the astrocyte marker glial fibrillary acidic protein (GFAP, green). Nuclear DNA was labeled with DAPI (blue). (E–G) Experiments in four separate biological donors were analyzed to quantify morphological activation. Individual dots on graphs represent compiled fold-changes calculated from duplicate wells and/or triplicate images per condition for each biological astrocyte donor. (E) GFAP intensity was measured across full-well scans using SoftMax Pro and normalized to DAPI. (F) Process length of individual astrocytes was manually traced and measured using ImageJ Software. (G) Percent morphological activation was calculated based on the number of astrocytes presenting with ‘reactive’ morphology divided by the total number of astrocytes imaged. (H) CCL2 and (I) <t>CXCL8</t> levels were assessed by an ELISA, and expression was normalized to metabolic activity prior to calculating fold changes to backbone. (J) Astrocytes were treated with 400 nM glutamate for 24 h. Remaining glutamate levels were quantified by fluorescent assay to calculate% glutamate clearance followed by fold change for each individual donor. Individual dots on graphs represent compiled data from triplicate experiments per biological astrocyte donor. Significance was determined by one-way ANOVA and Tukey’s post hoc for multiple comparisons.
    Il 8 Levels, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il 8 levels/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    il 8 levels - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    Image Search Results


    IRE1α overexpression augments cytokine expression and increases glutamate clearance in human astrocytes. Backbone and IRE1α transfected astrocytes were treated with IL-1β for 24 h. (A–D) Cells were immunolabeled with antibodies specific for IRE1α (red) and the astrocyte marker glial fibrillary acidic protein (GFAP, green). Nuclear DNA was labeled with DAPI (blue). (E–G) Experiments in four separate biological donors were analyzed to quantify morphological activation. Individual dots on graphs represent compiled fold-changes calculated from duplicate wells and/or triplicate images per condition for each biological astrocyte donor. (E) GFAP intensity was measured across full-well scans using SoftMax Pro and normalized to DAPI. (F) Process length of individual astrocytes was manually traced and measured using ImageJ Software. (G) Percent morphological activation was calculated based on the number of astrocytes presenting with ‘reactive’ morphology divided by the total number of astrocytes imaged. (H) CCL2 and (I) CXCL8 levels were assessed by an ELISA, and expression was normalized to metabolic activity prior to calculating fold changes to backbone. (J) Astrocytes were treated with 400 nM glutamate for 24 h. Remaining glutamate levels were quantified by fluorescent assay to calculate% glutamate clearance followed by fold change for each individual donor. Individual dots on graphs represent compiled data from triplicate experiments per biological astrocyte donor. Significance was determined by one-way ANOVA and Tukey’s post hoc for multiple comparisons.

    Journal: Frontiers in Neuroscience

    Article Title: A Non-Canonical Role for IRE1α Links ER and Mitochondria as Key Regulators of Astrocyte Dysfunction: Implications in Methamphetamine use and HIV-Associated Neurocognitive Disorders

    doi: 10.3389/fnins.2022.906651

    Figure Lengend Snippet: IRE1α overexpression augments cytokine expression and increases glutamate clearance in human astrocytes. Backbone and IRE1α transfected astrocytes were treated with IL-1β for 24 h. (A–D) Cells were immunolabeled with antibodies specific for IRE1α (red) and the astrocyte marker glial fibrillary acidic protein (GFAP, green). Nuclear DNA was labeled with DAPI (blue). (E–G) Experiments in four separate biological donors were analyzed to quantify morphological activation. Individual dots on graphs represent compiled fold-changes calculated from duplicate wells and/or triplicate images per condition for each biological astrocyte donor. (E) GFAP intensity was measured across full-well scans using SoftMax Pro and normalized to DAPI. (F) Process length of individual astrocytes was manually traced and measured using ImageJ Software. (G) Percent morphological activation was calculated based on the number of astrocytes presenting with ‘reactive’ morphology divided by the total number of astrocytes imaged. (H) CCL2 and (I) CXCL8 levels were assessed by an ELISA, and expression was normalized to metabolic activity prior to calculating fold changes to backbone. (J) Astrocytes were treated with 400 nM glutamate for 24 h. Remaining glutamate levels were quantified by fluorescent assay to calculate% glutamate clearance followed by fold change for each individual donor. Individual dots on graphs represent compiled data from triplicate experiments per biological astrocyte donor. Significance was determined by one-way ANOVA and Tukey’s post hoc for multiple comparisons.

    Article Snippet: Colorimetric enzyme-linked immunosorbent assays (ELISA) were performed according to the manufacturer’s instructions to quantify C-C motif chemokine ligand 2 (CCL2) and C-X-C motif chemokine ligand 8 (CXCL8) secretion levels in culture supernatants (CCL2, cat # DCP00; CXCL8, cat # D8000C, R&D Systems).

    Techniques: Over Expression, Expressing, Transfection, Immunolabeling, Marker, Labeling, Activation Assay, Software, Enzyme-linked Immunosorbent Assay, Activity Assay, Fluorescence

    Astrocyte IRE1α regulates ER stress, mitochondrial respiration, glycolysis, inflammation, and glutamate clearance.

    Journal: Frontiers in Neuroscience

    Article Title: A Non-Canonical Role for IRE1α Links ER and Mitochondria as Key Regulators of Astrocyte Dysfunction: Implications in Methamphetamine use and HIV-Associated Neurocognitive Disorders

    doi: 10.3389/fnins.2022.906651

    Figure Lengend Snippet: Astrocyte IRE1α regulates ER stress, mitochondrial respiration, glycolysis, inflammation, and glutamate clearance.

    Article Snippet: Colorimetric enzyme-linked immunosorbent assays (ELISA) were performed according to the manufacturer’s instructions to quantify C-C motif chemokine ligand 2 (CCL2) and C-X-C motif chemokine ligand 8 (CXCL8) secretion levels in culture supernatants (CCL2, cat # DCP00; CXCL8, cat # D8000C, R&D Systems).

    Techniques: Activity Assay